Continuous subcutaneous insulin infusion (CSII) does not prevent progression of proliferative and preproliferative retinopathy.
D000293:Adolescent; D000328:Adult; D003930:Diabetic Retinopathy / Q000473:pathology / Q000517:prevention & control*; D006801:Humans; D007263:Infusions, Parenteral; D007328:Insulin / Q000008:administration & dosage*; D008875:Middle Aged; D009389:Neovascularization, Pathologic / Q000473:pathology; D012160:Retina / Q000473:pathology
D007328:Insulin